- Home
- GBTG vs XENE Comparison
GBTG vs XENE Comparison
Compare GBTG & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GBTG | XENE |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.2B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GBTG | XENE |
|---|---|---|
| Price | $9.41 | $65.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | $8.92 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 2.4M | 1.7M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 173.33 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $2,718,000,000.00 | $311,000.00 |
| Revenue This Year | $21.78 | N/A |
| Revenue Next Year | $4.29 | $2,496.48 |
| P/E Ratio | $94.10 | ★ N/A |
| Revenue Growth | ★ 12.17 | N/A |
| 52 Week Low | $4.96 | $30.00 |
| 52 Week High | $9.54 | $72.66 |
Technical Indicators
Market Signals| Indicator | GBTG | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 69.55 | 57.41 |
| Support Level | $9.33 | $52.40 |
| Resistance Level | $9.46 | $72.66 |
| Average True Range (ATR) | 0.02 | 2.69 |
| MACD | -0.02 | -0.39 |
| Stochastic Oscillator | 66.67 | 42.85 |
Price Performance
Historical ComparisonAbout GBTG Global Business Travel Group Inc.
Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.